The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study

Bibliographic Details
Main Authors:	Thornhill, J, Herrera, C, Hoare, J, Peake, S, Brown, H, Nwokolo, N, Fox, J, Hanke, T, Frater, J, Fidler, S
Format:	Conference item
Language:	English
Published:	Wiley 2019

Similar Items

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection
by: Thornhill, JP, et al.
Published: (2019)

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
by: Thornhill, J, et al.
Published: (2019)

Advancing the HIV cure agenda: the next 5 years.
by: Thornhill, J, et al.
Published: (2015)

CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNA
by: Martin, G, et al.
Published: (2018)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery.
by: Thornhill, J, et al.
Published: (2017)

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
by: Frater, J, et al.
Published: (2019)

Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
by: Martin, GE, et al.
Published: (2017)

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
by: Genevieve E. Martin, et al.
Published: (2018-05-01)

Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment
by: White, C, et al.
Published: (2018)

Vorinostat (SAHA) and Breast Cancer: An Overview
by: Anna Wawruszak, et al.
Published: (2021-09-01)

The role of the gut mucosa in protection from HIV-1 in highly exposed persistently seronegative individuals (HEPS)
by: Fox, J, et al.
Published: (2009)

Vorinostat enhances the therapeutic potential of Erlotinib via MAPK in lung cancer cells
by: Amany I Alqosaibi, et al.
Published: (2022-01-01)

Immunotherapeutic approaches to HIV cure and remission
by: Lee, MJ, et al.
Published: (2021)

Lack of effect of Maraviroc intensification on blood and gut reservoir.
by: Tiraboschi, J, et al.
Published: (2016)

Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection
by: Fidler, S, et al.
Published: (2017)

Levels of human immunodeficiency virus DNA are determined before art initiation and linked to CD8 T-cell activation and memory expansion
by: Martin, GE, et al.
Published: (2019)

Differential Response of Mycosis Fungoides Cells to Vorinostat
by: Zachary A. Bordeaux, et al.
Published: (2023-04-01)

PP 3.10 – 00168 Vpr synergizes with vorinostat to prevent HIV-1 latency establishment
by: C. Lewis, et al.
Published: (2022-12-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
by: Foster, C, et al.
Published: (2017)

HIV-1 drug resistance in primary infections in the UK.
by: Fidler, S, et al.
Published: (2001)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
by: Jakub Kopycinski, et al.
Published: (2023-10-01)

HIV's gut feeling.
by: Sattentau, Q
Published: (2008)

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine
by: Roque Pastor-Ibáñez, et al.
Published: (2021-06-01)

A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study
by: Fidler, S, et al.
Published: (2017)

Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)
by: Calder, EDD, et al.
Published: (2020)

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.
by: Hanke, T, et al.
Published: (1998)

Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota
by: Alessandra Borgognone, et al.
Published: (2022-12-01)

Evaluation of circulating gut-homing T cells as a marker of HIV-1 progression and immune reconstitution
by: Dorrell, L, et al.
Published: (2014)

Gesicles packaging dCas9-VPR ribonucleoprotein complexes can combine with vorinostat and promote HIV proviral transcription
by: Michaela A. Fisher, et al.
Published: (2024-03-01)

Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells
by: Julia A. Sung, et al.
Published: (2017-09-01)

Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
by: Hoffmann, M, et al.
Published: (2016)

Effects of HIV, Immune Deficiency, and Confounding on the Distal Gut Microbiota
by: James J. Goedert
Published: (2016-03-01)

Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line
by: Nainong Li, et al.
Published: (2015-05-01)

Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells
by: Benigno C. Valdez, et al.
Published: (2023-11-01)

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
by: Fidler, S, et al.
Published: (2020)

Improved oral bioavailability of poorly water-soluble vorinostat by self-microemulsifying drug delivery system
by: Ashok Kumar Janakiraman, et al.
Published: (2022-08-01)

Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV
by: Ronald J. Ellis, et al.
Published: (2021-09-01)

Histone deacetylase inhibitors enhance CD4 T cell susceptibility to NK cell killing but reduce NK cell function
by: Pace, M, et al.
Published: (2016)

Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population
by: Panagiota Zacharopoulou, et al.
Published: (2024-03-01)

Vaccines against gut pathogens.
by: Mastroeni, P, et al.
Published: (1999)